Abstract:Objective To offered some prophase works by preparing Neurocan protein, antiserum, and assaying their characteristics, in order to construct the isopropy-β-D-thiogalactoside (IPTG)-participated DNA vaccine, which can neutralize the inhibitors in the injured CNS following the immune administration and then promote the nerve regeneration. Methods Neurocan gene was syntbetized with HisTag label in beginning and enzyme-cut sites at amphi- of the sequence. The prokaryotic expression plasmid, PET30a-Neurocan, was constructed as usual, converted into the Escherichia coli, and induced by IPTG to express positively. The interest protein was identified by SDS-PAGE and Western blot respectively. The preimmune serum was as the negative control during the ELISA assay of antiserum valency. The immune serum was as the first antibody, and the goat-anti-rabbit labeling with alkaline phosphatase (AP) was employed as the second one. Coloration was with NBT/BCIP method. Results The correct sequence of the synthetic Neurocan gene was clearly showed by identification with enzyme-cut, PCR and sequencing. The Neurocan protein expressed by prokaryotic showed its molecular weigh as 55 000 following the SDS-PAGE identification, and it could specifically bind with anti-HisTag, which implied the interesting protein just as the expression product of Neurocan gene. The valency of antiserum was shown by ELISA as 1:1 000 000, the purpose strap of which was confirmed by Western blot. Conclusions Neurocan protein could be successfully expressed in prokaryotic, the antibody of which could be specifically obtained by immune administration to the rabbit. The Neuroncan antibody could bind with the Neurocan protein specifically.

Protein Expression of Human Neuron-Specific Enolase and Its Antiserum Preparation.

Preparations of Specific Antibodies Against PrP N-terminal or C-terminal Peptides and Preliminary Study on Establishment of ELISA Diagnostic Method

Expression of PrP(C) As HIS-fusion Form in a Baculovirus System and Conversion of Expressed PrP-sen to PrP-res in a Cell-Free System.

Study on the molecular cloning of human neuron-specific enolase gene and preparation and identification of anti-NSE monoclonal antibodies

Expression and purification of human PrP-like protein Shadoo and preparation of antibody against Shadoo

Radioimmunoassay development for human neuron-specific enolase: with some clinical results in lung cancers and neuroblastoma

Prokaryotic Expression of Human Apolipoprotein E and Analyses of the Molecular Interaction Between ApoE and PrP Proteins in Vitro

Gene Express and Antibody Preparation of Neurocan Protein

Molecular Cloning and Prokaryotic Expression of Prion Gene from Mesocricetus Auratus

Cloning Prokaryotic Expression and Purification of Prion PrP~C51-216 from Ovis Aries

Optimization of the Isolation and Enrichment of S-Nitrosylated Proteins from Brain Tissues of Rodents and Humans with Various Prion Diseases for Itraq-Based Proteomics

Preparation and Preliminary Application of Recombinant Severe Acute Respiratory Syndrome Coronavirus (Sars-Cov) N Protein

Prokaryotic expression of human nervous system polycomb 1(NSPc1) and preparation of anti-NSPc1 polyclonal antibody

Cloning and High-level Expression of a Core Fragment Gene of Prion Protein from Sika Deer(Cervus nippon)

Guanidine hydrochloride extraction and detection of prion proteins in mouse and hamster prion diseases by ELISA

Expression of human heparanase protein and production of monoclonal antibodies against human heparanase

Expression and Purification of Hog Cholera Lapinised Virus Erns Gene in Escherichia coli

Prokaryotic Expression of Nanog Gene and Preparation of Anti-Nanog Antibody

Usage of neuron specific enolase in diseases of central nerve

Prokaryotic expression of NS1' protein resulted from ribosomal frameshifting in Japanese encephalitis virus and its immunoreactivity

Cloning and Expression of Neuraminidase Gene of Haemophilus Parasuis and Immunogenicity of Its Expressed Product